A new wave of technology is aiming to let machines “talk” to living systems using the language of ions and biomolecules. Known as bioiontronics, the field merges advances in iontronics with bioengineering to enable sensing and control of biological activity at the crucial boundary between synthetic materials and cells. Instead of relying only on electronic signals, bioiontronic devices convert information carried by ion concentration gradients and specific biomolecular cues into functional outputs.
At the heart of the approach is ion-mediated communication. Many biological processes—nerve firing, muscle contraction, inflammation signaling—are tightly linked to ionic fluxes and local chemical environments. Bioiontronic platforms leverage this coupling to detect physiological states, then modulate them through carefully engineered electric fields or ion-selective interactions. The result is a bridge between abiotic components and biotic processes that can, in principle, operate autonomously or as modular parts within larger biomedical systems.
The clinical motivation is straightforward: personalized medicine depends on extracting precise biomolecular information, such as ion levels and biomarker concentrations. By translating these biochemical signals into device-readable formats, bioiontronics could support diagnostics that are more sensitive to an individual’s ongoing physiology. Just as importantly, it may enable targeted therapeutic intervention that responds dynamically to measured conditions rather than using fixed treatment protocols.
Recent prototypes highlighted in the review emphasize the breadth of possible mechanisms, from bio-compatible sensing layers to interfaces designed for controlled ion transport. However, realizing these concepts in practical implants is not trivial. One persistent challenge is maintaining precise control of ion transport across device surfaces without disrupting biological function.
Another hurdle is miniaturization. As devices shrink to millimeter or micron scale, engineering uniformity, reproducibility, and signal fidelity become harder to maintain. Alongside this, long-term operation demands encapsulation strategies that are both biocompatible and durable, resisting degradation while still permitting functional coupling to ionic and biomolecular environments.
Finally, bioiontronics needs better tools to interpret multimodal biological signals. Real tissues rarely present a single clean readout; they generate overlapping ionic, chemical, and electrical patterns. Deciphering these streams—and then using them to drive appropriate device responses—remains a major systems-level challenge.
By synthesizing the mechanisms and engineering considerations behind bioiontronic devices, the review positions the field as a promising route toward next-generation biomedical interfaces. Yet it also makes clear that breakthroughs in ion transport control, packaging, device scaling, and signal interpretation will determine whether the technology can move from prototypes to reliable clinical platforms.
Subject of Research: Bioiontronics — ion- and biomolecule-based communication between devices and living matter.
Article Title: Bioiontronics.
Article References: Zhang, Y., Bayley, H. Bioiontronics. Nat Rev Bioeng (2026). https://doi.org/10.1038/s44222-026-00471-1
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s44222-026-00471-1
Keywords: Bioiontronics; iontronics; bioengineering; ion transport; biomolecular sensing; biocompatible encapsulation; multimodal biological signals.
